What are the risks of Nutropin therapy in CRI?
A small number of patients treated with GH have experienced pressure in the head (combined with visual changes, headache, nausea and/or vomiting). Patients with growth failure in CRI should have periodic check-ups for a type of bone disease called renal osteodystrophy. Additionally, some patients have experienced hip and/or knee pain, and others have experienced allergic reactions. Patients should contact their healthcare team immediately if they encounter these side effects.
